Reports for BAUSCH HEALTH, CANADA INC.
Company Name
BAUSCH HEALTH, CANADA INC.
Totals |
||
Shortage reports |
346 |
|
| Actual shortage: | 12 (3%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 34 (10%) | |
| Resolved: | 299 (86%) | |
Discontinuation Reports |
13 |
|
| To be discontinued: | 2 (15%) | |
| Discontinued: | 11 (85%) | |
| Reversed: | 0 (0%) | |
Late reports |
96 (27%) |
|
Overdue reports |
2 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TRYPTAN | 500MG | TABLET | Actual shortage | 2024-04-03 | 2024-04-04 | 224274 |
| TRYPTAN | 250MG | TABLET | Actual shortage | 2024-04-03 | 2024-04-04 | 224269 |
| TRYPTAN | 500MG | CAPSULE | Avoided shortage | 2024-04-03 | 2024-04-03 | 224266 |
| MESTINON | 60MG | TABLET | Resolved | 2024-03-20 | 2024-03-28 | 222851 |
| ROFACT | 300MG | CAPSULE | Actual shortage | 2024-03-18 | 2024-04-10 | 222584 |
| RETIN-A MICRO | 0.1% | GEL | Actual shortage | 2024-03-13 | 2024-04-09 | 222130 |
| RETIN-A | 0.05% | CREAM | Actual shortage | 2024-03-13 | 2024-03-28 | 222127 |
| ROFACT | 300MG | CAPSULE | Avoided shortage | 2024-02-22 | 2024-02-22 | 220173 |
| RETIN-A | 0.025% | GEL | Resolved | 2024-02-22 | 2024-04-03 | 220170 |
| CONTRAVE | 90MG 8MG | TABLET (EXTENDED-RELEASE) | Avoided shortage | 2024-02-01 | 2024-02-05 | 218165 |
| RETIN-A MICRO | 0.04% | GEL | Anticipated shortage | 2024-01-25 | 2024-04-11 | 217267 |
| ELIDEL | 1% | CREAM | Avoided shortage | 2024-01-25 | 2024-02-22 | 217264 |
| LODALIS | 625MG | TABLET | Resolved | 2024-01-25 | 2024-03-26 | 217261 |
| DELATESTRYL | 200MG | SOLUTION | Resolved | 2024-01-22 | 2024-02-01 | 216889 |
| NORITATE | 1% | CREAM | Resolved | 2023-12-20 | 2024-03-06 | 213952 |
| BIACNA TOPICAL GEL | 0.025% 1.2% | GEL | Resolved | 2023-12-15 | 2024-02-01 | 213471 |
| VIRAZOLE | 6G | POWDER FOR SOLUTION AEROSOL | Resolved | 2023-12-15 | 2024-01-29 | 213468 |
| EFUDEX | 5% | CREAM | Actual shortage | 2023-12-15 | 2024-03-20 | 213446 |
| CARBOLITH | 300MG | CAPSULE | Avoided shortage | 2023-12-06 | 2023-12-20 | 212587 |
| AIROMIR | 100MCG | METERED-DOSE AEROSOL | Resolved | 2023-11-27 | 2023-11-29 | 211577 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DELATESTRYL | 200MG | SOLUTION | To be discontinued | 2024-03-11 | 2024-03-11 | 221772 |
| VITAMIN A ACID | 0.025% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217848 |
| VITAMIN A ACID | 0.05% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217843 |
| VITAMIN A ACID | 0.01% | GEL | To be discontinued | 2024-01-30 | 2024-01-30 | 217835 |
| ALTACE HCT | 25MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214027 |
| ALTACE HCT | 12.5MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214024 |
| ALTACE HCT | 25MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214017 |
| ALTACE HCT | 12.5MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214014 |
| ALTACE HCT | 12.5MG 2.5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214011 |
| LIDEX | 0.05% | CREAM | Discontinued | 2023-12-08 | 2023-12-08 | 212804 |
| LODALIS | 3.75G | POWDER FOR SUSPENSION | Discontinued | 2023-12-08 | 2024-02-20 | 212799 |
| AIROMIR | 100MCG | METERED-DOSE AEROSOL | Discontinued | 2023-11-29 | 2023-11-29 | 211859 |
| THEOLAIR | 80MG | SOLUTION | Discontinued | 2021-04-26 | 2021-04-27 | 138081 |
Showing 1 to 13 of 13